Research / News

Research News

Filtered:

Nephrotoxicity (Remove filters)

Product launch - Human NGAL monomer-specific ELISA

BioPorto launches the first human NGAL monomer specific assay. 

Read more
Category
Diagnostics, Research
Clinical Relevance
Intensive care (ICU), Emergency room, Major organ surgery, Transplantation, Nephrotoxicity, AKI treatment, Other
Date

Launch of NGAL Monkey antibodies

Diagnostics is pleased to announce the launch of our first-in class NGAL Monkey antibody portfolio

The launch of NGAL Monkey antibodies is yet another step in our continued efforts to raise the focus on nephrotoxicity in drug discovery, and it makes our range on kidney related antibodies the most comprehensive on the market.

Read more
Category
Research
Clinical Relevance
Nephrotoxicity
Date

A new rapid NGAL assay for clinical chemistry platforms

A new assay simply known as The NGAL Test makes it possible to get an earlydiagnosis of acute kidney injury.

Read more
Category
Research
Clinical Relevance
Intensive care (ICU), Emergency room, Major organ surgery, Transplantation, Nephrotoxicity
Date

New Dog NGAL ELISA

BioPorto Diagnostics has launched a new ELISA test for the determination of the acute kidney injury marker NGAL in urine, plasma and serum from dogs.

Read more
Category
Research
Clinical Relevance
Major organ surgery, Transplantation, Nephrotoxicity
Date

New Rat NGAL ELISA

BioPorto Diagnostics has launched a new ELISA test for the determination of the acute kidney injury marker NGAL in rats.

Read more
Category
Research
Clinical Relevance
Nephrotoxicity
Date